# Amfora

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/amfora

- Industry: Biotechnology
- Headquarters: San Francisco, US
- Website: www.amforainc.com
- Total disclosed funding: $19M
- Latest round: Series B (Aug 11, 2021)
- Investors on record: 4

## About

Based in California, US, and founded in 2016, Amfora, Inc. provides plant-based replacements for animal protein and increasing the protein content of staple food crops. The company focuses on harnessing biology to meet the growing demand for protein by enhancing the nutritional content of food and feed crops, along with minimizing production costs and burden on the environment. In March 2021, Amfora, Inc. raised USD 6 million in a Series B funding led by Leaps by Bayer with participation from Spruce Capital Partners. With the Series B funding, the company has raised a total of USD 11 million funding. 

The company products include plant-based meat alternatives, protein-rich soybean, and protein-rich food crops including rice and wheat, Also, the company is focused on aquaculture for developing a low-cost, plant-based source of protein for farmed seafood. In addition, the company optimizes plant-based proteins’ amino acid profile, modifies carbohydrates to reduce their effect on serum glucose, and enhances micronutrients that help the body to utilize and absorb essential nutrients and promote wellness.  

The company generates revenue through manufacturing and distributing protein-rich food to meet the global demand. 

The company plans to use its proceeds from March 2021 funding to fuel its plant-based protein revolution.

## Funding rounds

- Series B, Aug 11, 2021, $7M — Spruce Capital Partners, Leaps by Bayer, BayWa Venture
- Series B, Jan 28, 2021, $7.3M — Spruce Capital Partners, Leaps by Bayer
- Series A, Apr 12, 2017, $5M — Spruce Capital Partners, Commonwealth Scientific and Industrial Research Organisation

## Investors

- Spruce Capital Partners (https://capitalatlas.ai/funds/spruce-capital-partners) — Series A, Series B
- Commonwealth Scientific and Industrial Research Organisation — Series A
- Leaps by Bayer (https://capitalatlas.ai/funds/leaps-by-bayer) — Series B
- BayWa Venture (https://capitalatlas.ai/funds/baywa-venture) — Series B